Gleason 4+3 Versus Gleason 3+4 Prostate Cancer: Still A Worse Prognostic Indicator Despite the Introduction of RAPC

被引：0
|
作者：
Broe, M. [1 ]
Forde, J. [1 ]
Burke, M. [1 ]
Shakeel, I. [1 ]
Lennon, G. [1 ]
Galvin, D. [1 ]
Mulvin, D. [1 ]
Quinlan, D. [1 ]
机构：
[1] St Vincents Univ Hosp, Dept Urol, Dublin 4, Ireland
来源：
IRISH JOURNAL OF MEDICAL SCIENCE | 2015年 / 184卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2
引用
收藏
页码：S384 / S384
页数：1
相关论文
共 50 条
  • [1] Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy
    Chan, TY
    Partin, AW
    Walsh, PC
    Epstein, JI
    UROLOGY, 2000, 56 (05) : 823 - 827
  • [2] Gleason Score and Lethal Prostate Cancer: Does 3+4=4+3?
    Stark, Jennifer R.
    Perner, Sven
    Stampfer, Meir J.
    Sinnott, Jennifer A.
    Finn, Stephen
    Eisenstein, Anna S.
    Ma, Jing
    Fiorentino, Michelangelo
    Kurth, Tobias
    Loda, Massimo
    Giovannucci, Edward L.
    Rubin, Mark A.
    Mucci, Lorelei A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (21) : 3459 - 3464
  • [3] Molecular Prognostic Testing on Gleason 3+4 Prostate Cancer
    Lin, Kirk
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 922 - 923
  • [4] Molecular Prognostic Testing on Gleason 3+4 Prostate Cancer
    Lin, Kirk
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 922 - 923
  • [5] Gleason score 7 prostate cancer on needle biopsy: Is the prognostic difference in Gleason scores 4+3 and 3+4 independent of the number of involved cores?
    Makarov, DV
    Sanderson, H
    Partin, AW
    Epstein, JI
    JOURNAL OF UROLOGY, 2002, 167 (06): : 2440 - 2442
  • [6] Incidence of metastasis and prostate-specific antigen levels at diagnosis in Gleason 3+4 versus 4+3 prostate cancer
    Kamel, Mohamed H.
    Khalil, Mahmoud I.
    Alobuia, Wilson M.
    Su, Joseph
    Davis, Rodney
    UROLOGY ANNALS, 2018, 10 (02) : 203 - 208
  • [7] Prostate Cancer Specific Mortality and Gleason 7 Disease Differences in Prostate Cancer Outcomes Between Cases With Gleason 4+3 and Gleason 3+4 Tumors in a Population Based Cohort
    Wright, Jonathan L.
    Salinas, Claudia A.
    Lin, Daniel W.
    Kolb, Suzanne
    Koopmeiners, Joseph
    Feng, Ziding
    Stanford, Janet L.
    JOURNAL OF UROLOGY, 2009, 182 (06): : 2702 - 2707
  • [8] Prostate Cancer Specific Mortality and Gleason 7 Disease Differences in Prostate Cancer Outcomes Between Cases With Gleason 4+3 and Gleason 3+4 Tumors in a Population Based Cohort COMMENT
    Dahm, Philipp
    JOURNAL OF UROLOGY, 2009, 182 (06): : 2707 - 2707
  • [9] The identification, internal and external validation of a biomarker panel to distinguish between Gleason 3+4 and 4+3 prostate cancer
    Oon, S. F.
    Fan, Y.
    Fitzpatrick, J. M.
    Klocker, H.
    Watson, R. W. G.
    BRITISH JOURNAL OF SURGERY, 2011, 98 : 48 - 48
  • [10] In Gleason 3+4 Prostate Cancer, Is Cribriform Growth More Influential Than Percent Gleason 4?
    Iczkowski, Kenneth
    Czaja, Rebecca
    Tarima, Sergey
    Wu, Ruizhe
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 569 - 569
12345